Key result
STE-ACS is linked to ~5-fold higher in-hospital mortality compared to NSTE-ACS.
Why the study?
The study aimed to analyze patient characteristics and treatment outcomes in ACS patients from a Thai private hospital registry, and compare outcomes between STE-ACS and NSTE-ACS.
Does in-hospital mortality differ between STE-ACS and NSTE-ACS patients in a private hospital network in Thailand?
Population
2,024 ACS patients across seven participating hospitals in Thailand
Comparison
STE-ACS vs NSTE-ACS
Design
Multicenter retrospective registry review
Authors
Loading...
STE-ACS was associated with higher in-hospital mortality than NSTE-ACS in this Thai cohort; leaves open generalizability and need for prospective validation.
Observational (n=2,024)
Yes
Does in-hospital mortality differ between STE-ACS and NSTE-ACS patients in a private hospital network in Thailand?
Absolute Event Rate: 4.95% vs 1.04%
p-value: p=< 0.001
In a Thai private hospital network, ACS patients had a high reperfusion rate and low overall in-hospital mortality (2.91%), though mortality remained significantly higher in STE-ACS compared to NSTE-ACS.
Hengrussamee et al. (2023) conducted an observational in Acute Coronary Syndrome (n=2,024). ST-segment elevation acute coronary syndrome (STE-ACS) vs. Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) was evaluated on In-hospital mortality rate (p=< 0.001). In-hospital mortality was significantly higher in patients with ST-segment elevation acute coronary syndrome compared to non-ST-segment elevation acute coronary syndrome (4.95% vs 1.04%, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: